510 related articles for article (PubMed ID: 11790115)
21. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
[TBL] [Abstract][Full Text] [Related]
22. Peripheral treatment with enoxaparin exacerbates amyloid plaque pathology in Tg2576 mice.
Cui H; King AE; Jacobson GA; Small DH
J Neurosci Res; 2017 Apr; 95(4):992-999. PubMed ID: 27546887
[TBL] [Abstract][Full Text] [Related]
23. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
[TBL] [Abstract][Full Text] [Related]
25. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
[TBL] [Abstract][Full Text] [Related]
26. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.
Chung E; Ji Y; Sun Y; Kascsak RJ; Kascsak RB; Mehta PD; Strittmatter SM; Wisniewski T
BMC Neurosci; 2010 Oct; 11():130. PubMed ID: 20946660
[TBL] [Abstract][Full Text] [Related]
27. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
[TBL] [Abstract][Full Text] [Related]
28. Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease.
Howlett DR; Bowler K; Soden PE; Riddell D; Davis JB; Richardson JC; Burbidge SA; Gonzalez MI; Irving EA; Lawman A; Miglio G; Dawson EL; Howlett ER; Hussain I
Histol Histopathol; 2008 Jan; 23(1):67-76. PubMed ID: 17952859
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models.
Kumar S; Lemere CA; Walter J
Acta Neuropathol Commun; 2020 Jul; 8(1):118. PubMed ID: 32727580
[TBL] [Abstract][Full Text] [Related]
30. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J
J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
[TBL] [Abstract][Full Text] [Related]
31. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
32. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
[TBL] [Abstract][Full Text] [Related]
33. Altered APP processing in PDAPP (Val717 --> Phe) transgenic mice yields extended-length Abeta peptides.
Esh C; Patton L; Kalback W; Kokjohn TA; Lopez J; Brune D; Newell AJ; Beach T; Schenk D; Games D; Paul S; Bales K; Ghetti B; Castaño EM; Roher AE
Biochemistry; 2005 Oct; 44(42):13807-19. PubMed ID: 16229470
[TBL] [Abstract][Full Text] [Related]
34. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
[TBL] [Abstract][Full Text] [Related]
35. Characterization of amyloid beta peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein.
Pype S; Moechars D; Dillen L; Mercken M
J Neurochem; 2003 Feb; 84(3):602-9. PubMed ID: 12558980
[TBL] [Abstract][Full Text] [Related]
36. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
37. Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice.
Park IH; Hwang EM; Hong HS; Boo JH; Oh SS; Lee J; Jung MW; Bang OY; Kim SU; Mook-Jung I
Neurobiol Aging; 2003 Sep; 24(5):637-43. PubMed ID: 12885571
[TBL] [Abstract][Full Text] [Related]
38. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
[TBL] [Abstract][Full Text] [Related]
39.
Jean L; Brimijoin S; Vaux DJ
J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102
[TBL] [Abstract][Full Text] [Related]
40. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.
Kawarabayashi T; Shoji M; Younkin LH; Wen-Lang L; Dickson DW; Murakami T; Matsubara E; Abe K; Ashe KH; Younkin SG
J Neurosci; 2004 Apr; 24(15):3801-9. PubMed ID: 15084661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
